Rifampicin-induced acute renal failure and hepatitis

Authors

  • Deni Kriscahoyo

DOI:

https://doi.org/10.24871/112000%25p

Abstract

Rifampicin is a potent drug and is the main drug in the multidrugs therapy for lung tuberculosis. We know this drug can induce hepatitis and nephritis in hypersensitive patient. The diagnosis of drug induced hepatitis is based on the fact that the patient was not ill before using the drug and become ill after taking it. In most cases the patient will improve after its withdrawal. We report a patient suffered from hepatitis and acute renal failure after using rifampicin and whose symptoms disappeared after stopping this drug. 
Key words: rifampicin, acute renal failure, hepatitis
VOLUME 1, ISSUE 1, December 2000

Downloads

Published

2000-01-12

How to Cite

Kriscahoyo, D. (2000). Rifampicin-induced acute renal failure and hepatitis. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 1(1). https://doi.org/10.24871/112000%p

Issue

VOLUME 1, NUMBER 1, December 2000

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).